Atlas Trials

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Clinical trial NCT02295748 · COMPLETED

Trial details

NCT number
NCT02295748
Sponsor
PTC Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2014-12-01
Primary completion
2017-08-24
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.